|MDACC Study No:||2010-0041 (clinicaltrials.gov NCT No: NCT00940602)|
|Title:||A multi-center, randomized, double-blind, placebo-controlled clinical trial of deferasirox in patients with myelodysplastic syndromes (low/int-1risk) and transfusional iron overload (TELESTO)|
|Principal Investigator:||Guillermo Garcia-Manero|
|Study Description:||The goal of this clinical research study is to study the effectiveness of the |
drug ExjadeŽ (deferasirox) in controlling MDS. Researchers will also study the
effect of the study drug/placebo on the heart, kidneys, and liver.